With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Influenza B is still outpacing other flu viruses in a season now 6 weeks old.
Three more Ebola cases have been confirmed in the Democratic Republic of the Congo (DRC), raising the outbreak total to 3,354 cases, according to numbers reflected on the World Health Organization (WHO) online Ebola dashboard.
Health officials are still investigating 488 suspected cases. Also, 3 more people died from their infections, lifting the fatality count to 2,220.
Today in Proceedings of the National Academy of Sciences (PNAS) British authors offered evidence supporting a long-observed phenomenon of the cold and flu season: Having either a rhinovirus or influenza makes a person less likely to contract the other virus.
According to the latest weekly update from the Global Polio Eradication Initiative (GPEI) today, Pakistan tracked three new cases of wild poliovirus type 1 (WPV1) this past week, while several African and Pacific island nations reported a total of 22 vaccine-derived polio cases.
Influenza B is still predominant, but H1N1 levels are rising; also, the CDC reports 4 new deaths in kids.
Patients with severe flu treated with a combination of the antiviral drugs favipiravir and oseltamivir compared with oseltamivir (Tamiflu) alone had faster recoveries, according to findings published today in The Journal of Infectious Diseases.
Outpatient visits for influenza-like illnesses jump from 2.9% to 3.5%.
Clinic visits for flulike illness are elevated for the 2nd week in a row.
An analysis of flu viruses during Japan's 2019 flu season suggests that 2009 H1N1 and H3N2 viruses can rapidly acquire the I38T mutation in the polymerase acidic (PA) protein, which has been linked to reduce susceptibility to baloxavir marboxil, a new antiviral. A team based Japan reported their findings yesterday in Nature Microbiology.
The percentage of clinic visits for flulike illness rose above the national baseline, and 1 more child has died from flu.
